Adjuvant multipeptide vaccination in high-risk renal cell carcinoma.

Susan Feyerabend,Cécile Gouttefangeas,Stefan Stevanovic,Dorothee Wernet,Jörg Hennenlotter,Jens Bedke,A Droege,Karoline Laske,Hans-Georg Rammensee,A. Stenzl

Adjuvant multipeptide vaccination in high-risk renal cell carcinoma.

2010

Susan Feyerabend
Cécile Gouttefangeas
Stefan Stevanovic
Dorothee Wernet
Jörg Hennenlotter
Jens Bedke
A Droege
Karoline Laske
Hans-Georg Rammensee
A. Stenzl

e15051 Background: We conduct an immunotherapy-based adjuvant phase I/II clinical trial using individual multi peptide vaccination in advanced or metastatic renal cell carcinoma after R0 resection....

Keywords:

Vaccination
Pathology
Adjuvant
Renal cell carcinoma
Medicine
Cancer research
r0 resection
Immunotherapy
Clinical trial
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations